Table 3.
Predictive model for chemotherapy-associated VTE
Patient characteristic | Risk score |
---|---|
Site of cancer | |
Very high risk (stomach, pancreas) | 2 |
High risk (lung, lymphoma, gynecologic, bladder, testicular) | 1 |
Prechemotherapy platelet count 350 × 109/L or more | 1 |
Hemoglobin level less than 100 g/L or use of red cell growth factors | 1 |
Prechemotherapy leukocyte count more than 11 × 109/L | 1 |
BMI 35 kg/m2 or more | 1 |